| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/23/2001 | WO2001061346A2 Methods for identifying agents causing a lethal phenotype |
| 08/23/2001 | WO2001061047A1 Methods for identifying signalling molecules |
| 08/23/2001 | WO2001061046A2 HUMAN VNO cDNA LIBRARIES |
| 08/23/2001 | WO2001061032A1 Immunoassay and diagnostic reagent for malaria |
| 08/23/2001 | WO2001061024A2 Rolling circle replicon expression vectors |
| 08/23/2001 | WO2001061021A2 Transgenic plants having resistance to a fungal disease |
| 08/23/2001 | WO2001061020A2 Alteration of growth and adaptation under hypoxic conditions |
| 08/23/2001 | WO2001061019A2 A dominant selectable marker for gene transformation and disruption in yeasts |
| 08/23/2001 | WO2001061018A1 Method of selecting transformant with high expression of target protein |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061013A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
| 08/23/2001 | WO2001061012A1 A method for generating hypermutable plants |
| 08/23/2001 | WO2001061011A2 Human thrombospondin repeat proteins and polynucleotides encoding the same |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001061006A2 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 08/23/2001 | WO2001061005A2 Molecules of the pyrin domain protein family and uses thereof |
| 08/23/2001 | WO2001061004A1 Novel protein having signal sequence |
| 08/23/2001 | WO2001061003A1 The human homologue of flamingo |
| 08/23/2001 | WO2001061002A1 Control of membrane traffic |
| 08/23/2001 | WO2001061001A2 Novel, central nervous protein, that modulates k+ flows |
| 08/23/2001 | WO2001061000A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 08/23/2001 | WO2001060999A1 Nucleic acid sequences characteristic of hematopoietic stem cells |
| 08/23/2001 | WO2001060997A2 Male tissue-specific regulatory region and method of using same |
| 08/23/2001 | WO2001060996A1 Method of controlling telomere length |
| 08/23/2001 | WO2001060984A1 Immortalized vascular adventitial cell line |
| 08/23/2001 | WO2001060983A2 Treatment for bone disorders |
| 08/23/2001 | WO2001060980A1 Transgenic, non-human animals containing a coxsackie/adenovirus receptor (car) |
| 08/23/2001 | WO2001060979A1 Pancreatic islet cell growth factors |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060974A2 Method for an extraction of proteins from a single cell |
| 08/23/2001 | WO2001060973A2 C/ebpbeta isoforms and methods of use in cell regulation and anti-tumorigenesis |
| 08/23/2001 | WO2001060972A2 Novel peptides and methods of use |
| 08/23/2001 | WO2001060970A2 Zinc finger domains and methods of identifying same |
| 08/23/2001 | WO2001060922A1 Process for the preparation of micronised collagen, and its therapeutic applications |
| 08/23/2001 | WO2001060866A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 08/23/2001 | WO2001060865A2 Novel proteins and nucleic acids encoding same |
| 08/23/2001 | WO2001060864A2 Human ion channels |
| 08/23/2001 | WO2001060863A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | WO2001060862A1 Vasoactive intestinal peptide analogs |
| 08/23/2001 | WO2001060861A1 Purification of vascular endothelial growth factor-b |
| 08/23/2001 | WO2001060860A2 Genes differentially expressed in human prostate cancer and their use |
| 08/23/2001 | WO2001060859A1 Novel proteins and novel genes encoding the same |
| 08/23/2001 | WO2001060858A2 Process for the preparation of a mucosal form of the eosinophil cationic protein (ecp), mucosal ecp and uses thereof as allergic phlogosis marker |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060856A2 Vmglom gene and its mutations causing disorders with a vascular component |
| 08/23/2001 | WO2001060855A1 A novel human cell cycle control-related protein and a sequence encoding the same |
| 08/23/2001 | WO2001060854A1 Novel members of the h+/oligopeptide transporter gene family |
| 08/23/2001 | WO2001060853A1 Transgenic animal model for obesity expressing foxc2 |
| 08/23/2001 | WO2001060852A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF |
| 08/23/2001 | WO2001060851A1 Staphylococcal enterotoxin sec-ser, expression vector and host cell, production method thereof, and manufacturing method of vaccine |
| 08/23/2001 | WO2001060850A1 Novel compounds |
| 08/23/2001 | WO2001060849A2 Cold-adapted equine influenza viruses |
| 08/23/2001 | WO2001060848A2 Conjugates targeted to target receptors |
| 08/23/2001 | WO2001060847A2 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | WO2001060839A2 Method for refolding recombinant endostatin |
| 08/23/2001 | WO2001060838A2 Aids ancestral viruses and vaccines |
| 08/23/2001 | WO2001060837A2 Polypeptoid pulmonary surfactants |
| 08/23/2001 | WO2001060794A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 08/23/2001 | WO2001060404A2 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 08/23/2001 | WO2001060403A1 Gm-negative ehv-mutants |
| 08/23/2001 | WO2001060397A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules |
| 08/23/2001 | WO2001060384A1 Inhibition of mal-1, the keratinocyte lipid binding protein |
| 08/23/2001 | WO2001060317A2 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 08/23/2001 | WO2001060162A2 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 08/23/2001 | WO2001060152A2 Transgenic non-human ucp2 knockout mammal |
| 08/23/2001 | WO2001060151A1 Mdel rats with the onset of prostatic cancer |
| 08/23/2001 | WO2001025793A3 Diagnosis of coeliac disease using a gliadin epitope |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001023522A3 Compositions and methods for p53-mediated repression of gene expression |
| 08/23/2001 | WO2001023521A3 Polypeptide derivatives of parathyroid hormone (PTH) |
| 08/23/2001 | WO2001019858A3 A family of ubiquitin-like proteins binds the atpase domain of hsp70-like stch |
| 08/23/2001 | WO2001016326A3 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (PFEMP1) that mediates adhesion to chondroitin sulfate A |
| 08/23/2001 | WO2001012799A3 Regulatory sequences for pollen specific or pollen abundant gene expression in plants |
| 08/23/2001 | WO2001012796A3 PKD constructs and screening methods |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001012657A3 Methods and means for selenoprotein expression |
| 08/23/2001 | WO2001012215A3 Protective antigen of Epstein barr virus |
| 08/23/2001 | WO2001011012A3 Human melanoma H11 gene polynucleotides, polypeptides, and methods of use |
| 08/23/2001 | WO2001010907A3 Therapeutic polypeptides and methods for using same |
| 08/23/2001 | WO2001010892A3 Peptide antagonists of factor VIIA |
| 08/23/2001 | WO2001009300A3 Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants |
| 08/23/2001 | WO2001009290A3 Avian infectious bronchitis virus serotype |
| 08/23/2001 | WO2001009283A3 Chimeric receptors and their uses |
| 08/23/2001 | WO2001009175A3 Plant defensin variants with modified cystein residues |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001007479A3 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 08/23/2001 | WO2001000842A3 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 08/23/2001 | WO2000078954A3 Human transcriptional regulator proteins |
| 08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
| 08/23/2001 | WO2000077177A3 Isolation of a human retrovirus |
| 08/23/2001 | WO2000071668A3 Method for identifying components involved in signal transduction pathways in higher plants |
| 08/23/2001 | WO2000061737A3 Production of attenuated negative stranded RNA virus vaccines |
| 08/23/2001 | WO2000055325A3 Plant centromeres |
| 08/23/2001 | WO2000042166A3 Methods and compositions for monitoring cellular processing of epitope-tagged beta-amyloid precursor protein |
| 08/23/2001 | WO2000006738A3 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 08/23/2001 | WO2000000615A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |